Dentsply Sirona (NASDAQ: XRAY) is a global manufacturer of professional dental products and technologies. The company is scheduled to report its first-quarter 2026 earnings on May 5 before the market opens. As highlighted by GlobeNewswire, Dentsply Sirona will also host an investor conference call that afternoon to discuss the financial results.
Wall Street's consensus estimate anticipates earnings of $0.28 per share. Revenue is projected to be around $841.80 million. According to Zacks Investment Research, their consensus revenue estimate is slightly lower at $840.10 million, but the earnings projection remains the same at $0.28 per share for the quarter.
Investors are watching for signs of stabilization as Dentsply Sirona faces several challenges. These include softness in the U.S. market and ongoing transformation costs that are impacting its profit margins. Despite these domestic issues, the company has noted resilience in its foreign markets, which could provide some support.
The company's financial health shows a debt-to-equity ratio of 1.84. This ratio indicates that the company uses more debt than its own funds to finance its assets. Its current ratio is 1.51, which is a measure of its ability to pay off short-term debts with its short-term assets.
